// App-Quantinova.ai

: Validation of a genomic risk classifier to predict metastasis and prostate cancer-specific mortality in men with positive lymph nodes.

Researchers

Presenter

  • Bruce J. Trock

Principal Investigators

  • R. Jeffrey Karnes

  • Frank Claessens

  • John W. Davis

  • Zaid Haddad

  • Kasra Yousefi

  • Elai Davicioni

  • Ashley Ross

Medical Centers

  • James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD

  • Mayo Clinic, Rochester, MN

  • University of Leuven, KUL, Leuven, Belgium

  • 1.MD Anderson Cancer Center, Houston, TX

  • GenomeDx Biosciences Inc., Vancouver, BC, Canada

  • Johns Hopkins Medicine, Baltimore, MD

Locations

  • United States

  • Belgium

  • Canada

Companies

  • GenomeDx Biosciences

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved